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Abbreviations 
AMP    Adenosine monophosphate 
ATP    Adenosine triphosphate 
aa-tRNA   Aminoacylated tRNA 
CRP     Catabolite regulation protein 
EF     Elongation factor 
FF     Fast Flow 
GDP    Guanosine diphosphate 
GPP     5’phosphorylase 
GTP    Guanosine triphosphate 
HPLC    High pressure liquid chromatography 
IC     Initiation complex 
IF     Initiation factor 
KO    knock-out 
LPS    Lipopolysaccharides 
MIC    Minimal inhibitory concentration 
MOPS   (3-N-morpholino)propanesulfonic acid 
MSI     Magic spot I 
MSII    Magic spot II 
ppGpp   guanosine tetraphosphate 
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pppGpp   guanosine pentaphosphate 
PTC    Peptidyl transferase centre 
QS    Quorum sensing 
RF    Release factor 
RRF    Ribosome recycling factor 
SAX     Strong anion exchange 
SD    Shine-Dalgarno (sequence) 
SF     Stringent factor 
TLC     Thin Layer Chromatography 
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 Abstract	  
 
The ability to adapt to environmental changes is essential for bacterial survival. One of the 
most important and most well-studied adaptive responses is the stringent response. When 
Escherichia coli experience starvation of amino acids or other nutrients the level of uncharged 
tRNA dramatically rises. This leads to a situation when a deacylated tRNA occupies the A-
site of the ribosome. The enzyme called RelA or Stringent Factor (SF) binds to the ribosomal 
A-site and catalyzes synthesis of compounds guanine nucleotide tetra- and penta-phosphates, 
collectively known as (p)ppGpp alarmone. These nucleotides are produced from ATP and 
GDP or GTP. The ppGpp concentration is primary, although not exclusive, player of growth 
rate control correlating the amount of rRNA produced in E. coli with bacterial growth rate.  
 
The accumulation of (p)ppGpp is important for bacterial virulence, differentiation and 
antibiotic resistance. Lately, chemical derivatives of (p)ppGpp were developed as  
competitive inhibitors of Rel proteins. One of these compounds which inhibits (p)ppGpp 
production in vivo and in vitro was purported as a novel antibacterial agent, Relacin. As Rel 
proteins are absent in mammals, this appears to be a very attractive approach of development 
of novel antibacterial agents.  
 
In our work we test Relacin on Gram-negative E. coli cells following its effects  on the 
growth rate. We try to develop a new method to measure nucleotide pools in living cells, 
since it is a important characteristics of bacterial physiological state. Using in vitro stringent 
response assay and translation assays we address the issue of Relacin’s selectivity. Our 
investigations of Relacin are a first step towards developing more potent and specific ppGpp-
based inhibitors of the stringent response.  
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Introduction 
 
1. Protein biosynthesis 
Proteins are biological molecules consisting of one or more poly-amino acid chains. They 
perform a various functions in living organisms, such as catalyzing metabolic reactions, 
responding to stimuli, replicating DNA, transporting molecules and so on. Proteins differ 
from one another in their amino acid sequence. The information contained in the DNA is 
transcribed into messenger RNA (mRNA). The four nucleotides (A, U, C or G) in the mRNA 
are translated into the 20 amino acids that make up proteins.  
The molecular machine performing this translation is called the ribosome. It is highly 
conserved, with its functional cycle and basic structure conserved across all three domains of 
life: Archaea, Bacteria and Eukarya. The bacterial ribosome consists of two subunits – the 
small subunit (30S) and the large subunit (50S). The small subunit consists of 16S rRNA and 
21 proteins whereas the large subunit consists of 23S rRNA, 5S rRNA and 31 proteins 
(Kaltschmidt & Wittmann, 1970). Together these subunits form the 70S ribosome. The cavity 
between two subunits where translational factors and tRNA bind is called the interface cavity 
(Lancaster et al., 2002). Two subunits have different tasks during the translational process. 
The 30S subunit contains the decoding region, is responsible for binding to the Shine-
Dalgarno sequence of mRNA and the interaction with the anticodon stem-loops of tRNAs in 
A-, P- and E-site (Schmeing & Ramakrishnan, 2009). 50S subunit contains peptidyl-
transferase centre (PTC) which is located in 23S rRNA. PTC is responsible for peptide bond 
formation between incoming amino acid in the A-site tRNA and the nascent peptide chain 
attached to the P-site tRNA (Schmeing et al., 2005). There is a GTPase associated region in 
the 50S subunit where elongation and release factors bind. Besides that, just as the 30S, the 
50S also contains tree binding sites for tRNA: the A-, P- and E-site (Figure 1).  
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Figure 1. The general outline of the ribosomal structre. Ribosomes are large ribonucleoprotein 
complexes, composed of both RNA and proteins and are responsible for protein synthesis in all living 
cells. Ribosomes consist of the small subunit (30S) and the large subunit (50S). These subunits form 
the 70S ribosome. The large subunit contains peptidyl transferase centre for peptide bond formation 
between amino acids. The small subunit is responsible for binding the Shine-Dalgrarno sequence of 
mRNA, interaction with the anticodon stem-loops of tRNAs in A-, P- and E-site and decoding. A-site 
is where tRNAs with amino acids bind (exception is the first amino acid), P-site contains the nascent 
peptide and E-site is the ribosomal site harbouring deacylated tRNA on transit out of the ribosome. 
The mRNA is stalled to separated subunits on the small subunit. Amino acids are bound to tRNAs and 
the tRNA with the growing peptide chain is in the P-site. Adapted from (Liljas, 2004). 
Since the experimental work presented in thesis was performed on bacterial system, I will 
focus on bacterial translational functional cycle.  
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 1.2	  Ribosomal	  functional	  cycle 
The cycle is sub-divided in three stages: initiation, elongation and termination (Figure 2).  
 
Figure 2. Functional cycle of the ribosome. The start point is on the lower right demonstrating the 
initiation of protein synthesis from separated subunits and mRNA binds to the small subunit. Bacteria 
have three Initiation Factors, IFs: IF1, IF2, IF3. IF3 binds to 30S and prevents premature association 
of subunits; IF1 stimulates activities of IF2 and IF3; IF2 is a GTPase that docks the initiator tRNA and 
catalyzes subunits association. In each of the elongation cycles one amino acid is added to the growing 
peptide chain. There are two main Elongation Factors, EFs, in bacteria EF-G and EF-Tu. EF-G is a 
GTPase and promotes the translocation of the A-site bound peptidyl-tRNA into the P-site; EF-Tu is 
also a GTPase and in complex with GTP catalzyes aminoacyl-tRNA (aa-tRNA) delivery to the A-site. 
When a stop codon is exposed in the A-site, the peptide is released. There are two class I Release 
Factors, RFs, in bacteria. RF1 is specific for codons UAG and UAA, RF2 for UGA and UAA. RF3 is 
a class II release factor and its function is to remove class I RF-s from the ribosome after they have 
completed the peptide release. Lastly, the ribosomes are recycled (split into subunits) for a new round 
of initiation by a concerted action of Ribosome Recycling Factor, RRF, and EF-G. Adapted from 
(Liljas, 2004). 
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1.2.1	  Translation	  initiation 
Bacterial mRNAs are frequently polycistronic, this means that more than one protein can be 
translated from one mRNA chain. Translation is initiated by the binding of an mRNA to the 
free ribosomal small subunits. The initiation of prokaryotic translation requires the assembly 
of components of translational system, namely: ribosomal 50S and 30S subunits, the mRNA, 
the initiator tRNA (fMet-tRNAifMet), energy source in the form of GTP and three Initiation 
Factors, IFs: IF1, IF2, IF3 (Gualerzi & Pon, 1990). Initiation factors provide the assembly the 
Initiation Complex (IC) (Malys & McCarthy, 2011) IF3 acts first and provides the assembly 
of ribosomal subunits (Gualerzi et al., 1977). IF1coordiantes the activities of IF2 and IF3 (Pon 
& Gualerzi, 1984). IF2 GTPase delivers the initiator aminoacyl-tRNA and is coordinating the 
subunit joining (Antoun et al., 2003).  
Translational GTPases, such as IF2, are a large family of hydrolase enzymes that can bind and 
hydrolyze GTP (to use as an energy source). A-site of the ribosome is the point of entry for 
the aminoacyl-tRNA (except first aminoacyl-tRNA which binds to the P-site). The P-site is 
where aminoacyl-tRNA is formed in the ribosome and E-site is the exit site for the uncharged 
tRNA after it gives its amino acid to the growing peptide chain. Large subunit of the ribosome 
has an exit tunnel for the polypeptide chain.  
During translation initiation, the initiation codon coding for methionine codon (AUG or 
GUG) has to be selected in the ribosomal P-site. In bacteria, the selection of the initiation 
methionine codon over elongation methionine codons or out of frame AUGs is done through a 
specific interaction of the so-called Shine-Dalgarno element (SD) of the mRNA with a 
specific element of the the small subunit ribosomal RNA – so-called anti-Shine-Dalgarno 
element (a-SD) (Shine & Dalgarno, 1974). In E. coli mRNAs typically have the SD sequence 
GGAGG located 7 ± 2 nucleotides upstream from the initiation codon (McCarthy & 
Brimacombe, 1994). As a result of the SD:a-SD is the complex formation of the initiation 
codon is positioned in the ribosomal P-site, ready for interaction with formulated methionine 
initiator tRNA. Once the pre-initiation complex is properly formed, the 50S subunit 
associates, GTP is hydrolyzed by IF2 and the initiation factors are released. The elongation 
phase of translation can begin.  
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1.2.2 Translation elongation 
Elongation of polypeptide chain means addition of amino acids to the carboxyl end of the 
chain until it is incorporated into the nascent peptide.  
At the start of the elongation cycle, the ribosome is in the post-translocation state with fMet-
tRNA or a peptidyl tRNA in the P-site. Conformational change from closed form to open 
form in the A-site allows new aminoacyl-tRNA to bind. When a codon from mRNA binds a 
cognate tRNA in the A-site, the small subunit undergoes a conformational change from an 
open to a closed form (Stahl et al., 2002). In the cell, most of the aminoacyl-tRNA is bound to 
complex EF-Tu GTPase in the complex with GTP which provides the binding to the A-site 
(Moazed & Noller, 1989). The binding and hydrolysis of GTP takes place in highly conserved 
G-domain (Scheffzek & Ahmadian, 2005). The P-site has the beginning of the peptide chain 
of the protein to be encoded and the A-site has the next amino acid to be added in the growing 
peptide chain (Valle et al., 2003). The growing polypeptide connected to the tRNA is then 
detached from the tRNA in the P-site. Peptide bond is formed between last amino acid of the 
polypeptide and the amino acid which is still attached to the tRNA in the A-site (Rodnina & 
Wintermeyer, 2003). The whole assembly in the A-site is called dipeptidyl-tRNA and P-site is 
deacylated. The final stage of elongation, the deacylated tRNA and dipeptidyl-tRNA along 
with its corresponding codons move to the E- and P-sites respectively, and new codon moves 
to the A-site. This process is catalyzed by the elongation factor G (EF-G) (Spirin, 2002). The 
deacylated tRNA at the E-site is released from the ribosome as soon as new aminoacyl-tRNA 
occupies A-site (Schmeing et al., 2003).  
The ribosome continues to translate the remaining codons on the mRNA until it reaches a stop 
codon (UAG, UGA, UAA). This is the beginning of termination. 
 
1.2.3 Translation termination 
The termination of translation occurs when one of the three stop codons move into the A-site: 
UAG, UGA, UAA (Nakamura & Ito, 2003). The stop codon is recognized by specific protein 
factors called Release Factors, RFs. In bacteria, there are two class I release factors: RF1 and 
RF2. The Class I release factor RF1 recognizes stop codons UAA and UAG, while RF2 
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responds to UAA and UGA (Scolnick et al., 1968). The release factors decode the stop 
codons and hydrolyze the completed peptide from the P-site tRNA. The hydrolysis may be 
induced directly or indirectly (Nakamura & Ito, 2003). Besides Class I RF proteins some 
bacteria also have a class II release factor, RF3 (Goldstein & Caskey, 1970). Class II RF 
removes class I RF-s from the ribosome after they have released a peptide chain from the 
ribosome. GTP is hydrolyzed on RF3 which helps RF1 and RF2 to dissociate and RF3 itself 
dissociates (Gao et al., 2007). The recycling step of the translation may begin.  
 
1.2.4 Ribosomal recycling 
When the ribosome has reached a stop codon and the peptide is released, the extensive 
machinery of the ribosome has to be reused. This machinery consists of mRNA with the 
termination codon at the A-site, an uncharged tRNA at the P-site and the intact 70S ribosome. 
Since the mRNA is threaded through the tunnel between the subunits and is in intimate 
contact with the neck region of the small subunit and the deacylated tRNA has tight 
interactions in the P-site, the subunits would probably have to open up or probably even 
dissociate. For a new initiation, they have to be separated since the initiation is done with the 
small subunit alone. The Ribosome Recycling Factor (RRF) participates in this process 
together with EF-G. After the GTP hydrolysis the ribosomal subunits dissociate (Savelsbergh 
et al., 2009). The initiation factor IF3 prevents subunits from re-association, releases the 
deacylated tRNA from the P-site and mRNA from the small subunit (Savelsbergh et al., 
2009). The ribosome is ready for the new round of the protein synthesis. 
 
 
2. The stringent response 
”It is not the strongest of the species that survives, nor the most intelligent that survives. It is 
the one that is most adaptable to change” (C. Darwin) 
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The ability to adapt to environmental changes is the key component of the survival of bacteria 
and those who don’t have that ability face the chance to be eliminated. Regulatory 
mechanisms which help bacteria to maintain their balanced and rather constant cellular 
composition mostly occur at the genetic level. One of the most important and the most studied 
adaptive response to stress conditions is the so-called stringent response.  
2.1 General mechanism of the stringent response  
One of the stressful conditions bacteria encounter is lack of amino acids or other nutrients in 
the environment. This, in turn, causes the condition called the stringent response. 
During nutrient starvation, Escherichia coli elicits the stringent response to conserve energy 
and re-program its metabolism for survival. Repression of the transcription of stable RNA 
species like tRNA and rRNA (Deutscher, 2009)  and the up-regulation of transcription of 
genes coding the enzymes involved in amino acid biosynthesis are some of the effects of 
stringent conditions (Deutscher, 2009).  
The stringent response to amino acid starvation is mediated by a protein called the stringent 
factor or RelA (Chatterji & Ojha, 2001). RelA binds to a ribosome to an unacylated tRNA in 
the amino-acyl site (A-site) since there is a lack of amino acids. The RelA binds to blocked 
ribosomes and catalyzes synthesis of an unusual guanosine phosphate, an alarmone called 
(p)ppGpp. RelA utilizes ATP and GTP or GDP to produce AMP and pppGpp or ppGpp 
respectively (Figure 3) (Wendrich et al., 2002). The alarmone interacts with the RNA 
polymerase that is responsible for transcription DNA to RNA in the cell and this results in a 
rapid down-regulation of stable RNA biosynthesis (tRNA and rRNA). 
 
Figure 3. The chemical reaction catalyzed by RelA. The stringent factor RelA binds to stalled 
ribosomes and converts GTP and ATP into pppGpp by adding the pyrophosphate from ATP onto the 
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3’ carbon of the ribose in GTP releasing AMP. pppGpp is converted to ppGpp by GPP, releasing extra 
phosphate group. 
Bacteria have evolved a range of cell-cell signaling mechanisms to determine population 
density (quorum sensing) and to initiate certain processes only when a certain number of 
bacteria is reached. This kind of signaling is referred to as bacterial social behavior and is 
related to such phenomena as biofilm formation. Biofilms consist of aggregates of multiple 
cells in close proximity. High population densities, necessary to reach “quorum”, correlate 
with the deficiency of nutrients and entry into the stationary phase. Therefore it is not 
surprising that quorum sensing stress- and starvation-pathway seem to be connected with 
(p)ppGpp regulation (Braeken et al., 2006). 
The stringent response has also been detected not only in bacteria but in plants. The best 
example is Arabidopsis thaliana. There were found a functional RelA-SpoT (major proteins 
in the stringent response) homologue as well as bacterial type RNA polymerase in 
chloroplasts. When plants were treated with plant hormones such as jasmonic acid and 
abscisic acid which are known to play a significant role in signal transduction network, an 
elevated level of ppGpp was noticed (Takahashi et al., 2004). It was suggested that (p)ppGpp 
was mediating a stress-induced defense system (van der Biezen et al., 2000).  The findings 
propose that the stringent response has been conserved through evolution and thus contributes 
to the adaptation of plants to environmental changes analogous to that seen in bacteria. 
Observation suggest that the (p)ppGpp regulatory system is operative in chloroplasts of higher 
plants (Braeken et al., 2006). 
2.2 E. coli RelA- and SpoT-mediated metabolism of ppGpp 
There are two pathways responsible for modulating the (p)ppGpp level in E. coli – RelA- and 
SpoT-dependent pathways. 
Historically, first proteins which were involved in both synthesis and degradation of 
(p)ppGpp were the products of genes relA and spoT. Products of these genes proteins RelA 
and SpoT gave a name to the protein family RelA-SpoT-Homologue, RSH (Atkinson et al., 
2011). The spoT and relA genes have been suggested to evolve separately after gene 
duplication of an ancestral rel-like gene (Mittenhuber, 2001). It was shown that after the 
amino acid alignment of Rel and SpoT of E. coli the identity was only 29 % whereas after the 
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alignment of SpoT and bifunctional protein Rel of Gram-positive bacteria the results were 
higher. This suggests that bifunctional Rel is related to SpoT, both have synthetic and 
hydrolytic activities (Jain et al., 2006).  
The first gene encoding the amino acid starvation response in E. coli was discovered in sixties 
by Stent and Brenner (Stent & Brenner, 1961) and dubbed as relA – “relaxed” (i.e. unable to 
respond to amino acid starvation) phenotype A. It has been shown that the initiation of 
transcription from relA gene can occur at two promoters – relAP1 and relAP2. One site is 
located 178 bp upstream of the RelA translational start site, the second is located 626 bp 
upstream. Both promoters are shown to be regulated by house-keeping sigma factor σ70. The 
promoter relAP1 was suggested to be active during all growth phases but the signal from 
relAP2 was transiently induced at the transition state between the exponential growth phase 
and the stationary phase. It has also been shown that relAP1 promoter is dependent on an UP-
stream-like sequence. It is AT-rich sequence which locates around 40 bp upstream of the 
transcriptional start-site and enhance promoter recognition by RNA polymerase. relAP2 
seems also to be regulated by CRP (Catabolite Regulation Protein) region which is centered 
61 bp upstream from the transcriptional start site (Nakagawa et al., 2006, Metzger et al., 
1988).  
The second pathway for ppGpp production in E. coli  is the SpoT-dependent pathway which 
involves a product from the spoT gene. The spoT gene was first mentioned by Laffler and 
Gallant in “spotless” phenotypes where although large quantities of ppGpp accumulated the 
quantities of pppGpp stayed scarcely detectable (Laffler & Gallant, 1974) SpoT has a ppGpp 
hydrolysis activity. Although SpoT is responsible for degradation (p)ppGpp in the cell it has a 
low synthetic activity as well (Xiao et al., 1991). For bacteria that also encode RelA, their 
bifunctional SpoT enzymes respond to variety of stimuli, including phosphate, carbon and 
iron starvation, as well as perturbations in fatty acid metabolism (Potrykus & Cashel, 2008). 
Unfortunately a little is known on molecular mechanisms which trigger the SpoT-dependent 
synthesis of (p)ppGpp (Magnusson et al., 2005). 
Recently two additional factors (YwaC and YjbM) were found to have (p)ppGpp-synthetase 
activity in B. subtilis (Nanamiya et al., 2008). 
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2.4 (p)ppGpp 
The alarmones nucleotides implicated in the stringent response were first called ”magic spots” 
– MSI and MSII (Haseltine et al., 1972). They were identified as guanosine tetra phosphate 
(ppGpp) and guanosine penta phosphate (pppGpp) (Cashel & Kalbacher, 1970), collectively 
called (p)ppGpp. After the activation of the stringent factor it triggers the synthesis of ppGpp 
by donation of β-and γ-phosphates from ATP to GTP or GDP, the major product in vivo 
being pppGpp (Figure 4).  
 
Figure 4. Cellular pathways of (p)ppGpp metabolism. The enzymes responsible for the metabolism 
are represented by their genes: relA, spoT, gpp and ndk (nucleoside 5’diphosphate kinase – catalyzes 
the exchange of phosphate groups between different nucleoside diphosphates). 
5’phosphorylase (GPP) degrades penta phosphate to ppGpp and it binds to RNA polymerase, 
acting as an effetor molecule. RNA polymerase consists of two α and two β subunits, 
altogether they form the RNAP core (α2ββ’). Sigma factors (σ factors – in E. coli seven 
different) can bind to this core region and give specificity for particular promoter and 
transcription of specific genes. ppGpp is believed to bind to the β and β’ subunits 
(Toulokhonov et al., 2001). It can act both as positive and negative regulator of transcription. 
In general, σ70-dependent genes involved in cell proliferation and growth are negatively 
regulated (Barker et al., 2001), genes involved maintenance and stress defense are positively 
regulated by the alarmone (Nyström, 2004). The main cellular processes regulated by ppGpp 
are shown in Table 1. 
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Table 1. Summary of upregulated and downregulated cellular processes affected by (p)ppGpp 
Downregulated Upregulated 
DNA replication Amino acid biosynthesis 
tRNA and rRNA synthesis Long-term persistence and virulence 
Protein synthesis Universal stress protein synthesis 
Ribosome biogenesis Synthesis of sigma factors 
Translation initiation and elongation Virulence gene expression 
Nucleotide biosynthesis Antibotic resistance 
Phospholipid synthesis Toxin/antitoxin systems 
Oxidative metabolism Carbohydrate metabolism 
Cell division Chaperones and proteolysis systems 
Cell motility Cyclopropane fatty acid synthesis 
Metabolite transport  
 
 
3. The stringent response as a target for antibacterial compounds 
The goal of every pathogen is to survive in the environment and replicate. To overcome the 
defense mechanisms of their hosts, bacteria have obtained traits associated with virulence, 
such as cell or surface invasion, surface attachment and transmission. Numerous pathogens 
couple their common virulence pathways with more general adaptions, like stress resistance, 
by integrating dedicated regulators with global signaling networks. Many bacteria rely on 
alarmones to cue metabolic disturbances and coordinate survival and virulence programs.  
It has been shown that response controlled by the alarmone (p)ppGpp is widespread and 
involves many features important for cell physiology and not only during growth but also 
during stationary conditions (Mouery et al., 2006). 
3.1 Role of the stringent response in bacterial virulence 
The appearance of (p)ppGpp in starved cells is correlated with cessation of rRNA synthesis 
and is referred to as the stringent response (Potrykus & Cashel, 2008). Bacterial and plant 
cells that experience nutritional stress synthesize ppGpp to initiate global physiological 
changes. The alarmone generally functions to promote the adaption and flexibility of bacterial 
cells faced with adversity.  
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In heterogeneous environments which are mammalian and plant hosts bacteria have to alter 
their metabolism and protein repertoire in response to local conditions. Bacterial adaption can 
be triggered by changes in nutrient supply, alternations in immune responses or contact with 
new surfaces. To gain an advantage in changing environmental conditions bacteria can 
activate specialized secretion systems, motility organelles or adhesins. Adhesins are cell-
surface components of bacteria that help bacterial adhesion or adherence to other cells or 
inanimate surfaces. All these factors help bacteria to get access to nutrients, modulate host 
cell immune system or migrate to more favorable locations. Altogether they are called 
virulence factors or regulators. The expression and activity of many virulence regulators are 
integrated into a global response mediated by ppGpp, thereby coupling pathogenesis to 
metabolic status (Dalebroux et al., 2010). 
Bacteria have evolved a number of cell-cell signaling mechanisms to determine the 
population density – quorum sensing (QS). This kind of phenomena is related to biofilm 
formation and is interpreted as bacterial social behavior. QS and biofilms formation are often 
associated with virulence and infections. Very persistent biofilms which form from bacteria in 
their stationary phase are a huge problem in medical world, because antibiotics can’t target 
inactive cells (Anderl et al., 2003).  
The effect of (p)ppGpp level on virulence determinants have been studied mostly in 
pathogenic bacteria belonging to the γ-proteobacteria, revealing that the importance of the 
RelA and SpoT homologue when they occur together in a signal bacterium may differ 
between the species. For example, RelA fulfills an important role in modulating the ToxR 
regulon (transcription of transcriptional activator ToxR, as a result production of cholera toxin 
and the transcription of toxin-coregulated pilus are severely reduced) in Vibrio cholerae 
(Haralalka et al., 2003), SpoT but not RelA regulates virulence in Salmonella typhimurium 
mainly through expression of hilA (transcriptional regulator of pathogenic gene expression) 
and the expression of plasmid-born virulence in response to environmental changes (Pizarro-
Cerda & Tedin, 2004) (Song et al., 2004).  Moreover, the expression of RelA in Legionella 
pneumophila was shown to induce expression of several virulence traits (Hammer & 
Swanson, 1999).  
In some bacteria such as Clostridium and Bacillus spp. The response to starvation is to form 
metabolically inactive endospores which are quite effective form of resistance to starvation 
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and stress conditions such as heat and dehydration. It is a measure for a long-term survival for 
Gram-positive bacteria (Piggot & Hilbert, 2004). Entry into sporulation is triggered by the 
decrease in intracellular GTP nucleotide pools which is converted to (p)ppGpp by RelA 
(Lopez et al., 1979). 
The precise mechanism used by the alarmone (p)ppGpp to regulate virulence has still 
remained unstudied but it has been noted that it resembles to one found in E. coli –  biofilm 
formation is decreased in spoT relA mutants (Balzer & McLean, 2002).  
3.2 ppGpp analogues as stringent response inhibitors 
At present, most of the drugs administered to treat bacterial infections are aimed to protein 
synthesis, nucleic-acid synthesis, cell wall synthesis or folate synthesis (Walsh, 2003).The 
stringent response is a potential target for antibiotics because it is crucial for activation of 
survival strategies, such as sporulation, stationary phase and biofilm formation (Jain et al., 
2006). It has been shown that the stringent response mediates antibiotic tolerance in nutrient-
limited bacteria (Nguyen et al., 2011). As the stringent response is induced by the 
accumulation of (p)ppGpp recently Wexselblatt and colleagues started to synthesize 
compounds which chemical structure is close to (p)ppGpp (Wexselblatt et al., 2008). They 
have used the crystal structures of RelA analogues. In their experiments they use full-length 
RelA from E. coli which N-terminal domain has (p)ppGpp-synthethase activity and C-domain 
is ribosome binding domain and the RelA homologue Relseq385 which has a bifunctional N-
terminal domain of Straphyloccoccus equisimilis; (p)ppGpp synthetase and hydrolase 
activities are in two separate catalytic sites and the recombinant protein construct lacks of C-
terminal ribosome binding site (Wexselblatt et al., 2012). One of their latest works is the 
novel antibacterial agent called Relacin (Figure 5) which they claim to inhibit E. coli RelA in 
vitro and reduce (p)ppGpp production in vivo in Bacillus subtilis. Ultimately Relacin must 
perturb the switch into stationary phase and lead to bacterial death (Wexselblatt et al., 2012).  
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Figure 5. The structure of Relacin. Based on the Rel/Spo crystal structure Wexselblatt and 
colleagues designed Relacin a 29-deoxyguanosine-based analogue of ppGpp, in which the original 
pyrophosphate moieties at position 5’ and 3’ were replaced by glycyl-glycine dipeptides linked to the 
sugar ring by a carbamate bridge. Modeling the binding of Relacin to the Rel/Spo synthetase site 
shows that it occupies a considerable volume of the binding pocket   and   forms   a   range   of   
hydrogen   bonds   and   hydrophobic interactions, providing structural   basis   for   the inhibitory 
effect of Relacin (Wexselblatt et al., 2012). 
 20	  
	  	  	  Aims	  of	  the	  project 
In our research we focus on defining the molecular mechanisms of the bacterial-mediated 
RelA stringent response using a combination of in vivo and in vitro techniques. The stringent 
response plays a formative role in bacterial physiology, especially in bacterial virulence, 
biofilm formation and antibiotic tolerance. Besides, we try to complete well-known 
techniques and elaborate the techniques being still in the process of development.  
The specific aims are:  
(i) to elucidate of the mechanism of RelA by its product ppGpp, to characterize the RelA 
mediated stringent response in vivo by specifying quantities of nucleotide pools (especially 
intracellular ppGpp levels) in living cells; 
(ii) to characterize RelA mediated stringent response in vitro in the presence of the compound 
Relacin; to confirm the theory that Relacin works as RelA inhibitor by occuping its reactive 
center and ppGpp synthesis decreases; 
(iii) to test Relacin on bacterial culture and define its effect on bacterial growth and status in 
metabolic changes; 
(iiii) to develop, complete and learn new methods in following the RelA mediated stringent 
response in cell-free system and on bacterial culture to test novel stringent response inhibitors. 
The defining mechanisms of SR have two major fields of application: biotechnological and 
clinical. In the clinical context, an efficient stringent response inhibitor would be a highly 
desired anti-virulence antimicrobial. In the biotechnological context it could be used for 
modulation of various stringent response biotechnologically relevant cellular processes like 
antibiotic and protein production. 
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    Experimental	  part	   
1. Materials and methods 
1.1 Measuring nucleotide pools in E. coli 
Bacteria and culture conditions. E. coli strain AS 19 was used. It is a strain with defective 
lipopolysaccharides and is therefore more permeable to antibiotics (Good et al., 2000). 
Bacteria were grown in MOPS media (Neidhardt	   et	   al.,	   1974) that consisted of 0.4% 
glucose, 1xMOPS concentrate (Table 2), 9.52 mM NH4Cl and 1.32 mM K2HPO4 (the 
concentrate is made without ammonium and phosphate to induce nitrogen and phosphate 
starvation if necessary). Antibiotic mupirocin was added at 0.3 µg/ml [that is 3 times of our 
determined Minimal Inhibitory Concentration (MIC) for AS19]. 
	  Table	  2.	  10xMOPS concentrate 
Components Concentration K2HPO4 1.32 mM NH4Cl 9.52 mM MgCl2 0.523	  mM K2SO4 0.276 mM FeSO4 0.010 mM CaCl2 5*10-­‐4 mM NaCl 50 mM MOPS 40 mM Tricin 4 mM 
Microelements  (NH4)6(MO7)24 3*10-­‐6 mM H3BO3 4*10-­‐4 mM CoCl2 3*10-­‐5 mM CuSO4 10-­‐5 mM MnCl2 8*10-­‐5 mM ZnSO4	   10-­‐5 mM 
  
Growing and collecting cells for nucleotide extraction.	   We started an overnight (O/N) 
culture in 3 ml of 0,4% Glu MOPS transferred to 37 °C shaker (180-220 rpm). Next day, we 
inoculated 200 ml prewarmed MOPS in 1 l flask from O/N culture; dilution was 1:100 (so we 
added 2 ml of O/N culture). Culture was grown at 37°C shaker until OD600 was 0.5. Usually 
it took up to 5 hours.  
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The next step was to collect cells. We poured cell cultures onto formic acid (final 
concentration 1 M) and transferred the tubes immediately into liquid nitrogen. The samples 
were transferred to -80 °C to store the samples for further preparation and analysis. 
Nucleotide extraction and sample preparation for HPLC. Samples from -80 °C were 
thawed at 37 °C water bath for 10 minutes. It was important not to let samples to get too much 
heat, as nucleotides were stable only in cold formic acid. After thaw, nucleotides were 
extracted for 30 minutes on ice with frequent vortexing. Insoluble material was then pelleted 
at 7000 G for 7 minutes at 4 °C (Sigma 4K15C centrifuge) and supernatants were filtrated 
with 0.2 µm syringe-filter.  
For the enrichment of nucleotides, BioLogic LP (BioRad) system at 4°C refrigerator was used 
with a 1 ml Q-sepharose Fast Flow (GE Healthcare) column matrix. Column was equilibrated 
with cold mQ H2O at highest flow rate in purge regime (6-7 ml/min). Sample was diluted 20 
times in cold mQ water and loaded onto the column at 5-6 ml/min. After sample was loaded, 
column was washed with about 15 mL of water. Next, column-bound material was eluted 
with 2 M LiCl in 25 mM Tris pH 8 with a flow rate of 1 ml/min. Elution was followed at 254 
nm, after about 3 minutes a peak appeared, we waited for another minute for the fraction to 
reach the sample collector and collected the fraction for 4-5 minutes. After collection, column 
was washed with 5-10 ml of 2 M LiCl in 25 mM Tris pH 8. When not in use, column was 
stored in 20 % ethanol. 
For the precipitation of nucleotides, 4 volumes of 96 % ethanol (-20 °C) and 4 µl of ice-cold 1 
M K2HPO4 were added to collected fraction. The salt was included to help the formation of 
precipitate and to ease the handling of precipitate. Sample was left to precipitate over night at 
-20 °C. Next day, sample was centrifuged for 20 minutes at 5525 G at 4 °C using a swing-out 
rotor (centrifuge Sigma 4K15C) to collect the precipitate. Supernatant was discarded and 
precipitate was washed with 5 ml of 70 % cold ethanol and centrifuged for another 20 minutes 
at 5525 G at 4 °C. Supernatant was again discarded and precipitate was first dried by short 
lyophilization (about 20 min) and then dissolved in 400 µl of cold mQ with heavy vortexing. 
The sample was transferred to 1,5 ml Eppendorf and centrifuged at maximum RPM (about 
14,000-16,000 G) for 20 minutes at 4 °C to remove extra salt and other insoluble material, as 
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salt may cause additional peaks when running HPLC. The supernatant (about 350 µl) was 
collected to new tube that was pre-chilled on ice (Figure 6). 
HPLC (High Pressure Liquid Chromatography) assay of nucleotides. HPLC was 
performed by anion-exchange chromatography on Agilent 1100 system with a diode array 
detector. Nucleotides were separated on 4.6 by 150 mm S5 SAX column either from 
Phenomenex (Sphereclone S5 SAX) or from Waters (Spherisorb S5 SAX) with latter one 
giving slightly better resolution. Analytical column was equipped with a Phenomenex SAX 
guard column and chromatography was performed at 27 °C. Guanosine nucleotides were 
detected at 252 nm and adenosine nucleotides at 259 nm with a bandwidth of 4 nm. At a flow 
rate 1 ml/min, a linear gradient of 0:100 to 100:0 (A:B) was run for 30 min, from 30 to 45 min 
0:100 was held. Buffer A was 0.05 M ammonium phosphate (pH 3.4) and buffer B was 0.5 M 
ammonium phosphate (pH 3.4). Injection volume was mostly 100 µl. 
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Figure 6. The main steps of the nucleotide sample preparation. Those steps include growing the 
bacteria in MOPS minimal medium adding 0.4 % glucose, filtration and dilution the sample 20 fold 
and passing over SAX Q-sepharose FF column. The samples are eluted from column with 2 M LiCl in 
25 mM Tris pH 8, precipitated O/N in 96 % ethanol in the presence of 1 M K2HPO4 at -20 °C. 
Samples are centrifuged, washed with cold 70 % ethanol. Finally samples are collected in mQ. Then 
run on HPLC.  
 
1.2 In vitro stringent response assay To	   test	   Relacin	   effect	   on	   stringent	   response	   we	   monitored	   how	   it	   affects	   the	   RelA	  mediated	   ppGpp	   synthesis.	   Several	   reaction	   mixes	   were	   prepared	   with	   0.5	   µM	   70S	  ribosomes,	   100	   uM	   ppGpp,	   300	   uM	   (3H)GDP	   (American	   Radiolabelled	   Chemicals),	   0.1	  
Cells	  grown	  in	  MOPS	  medium	  
to	  desired	  OD600	  
Growth	  stopped	  by	  pouring	  
on	  formic	  acid	  and	  rapidly	  
freezing	  in	  liquid	  nitrogen	  
Cells	  transferred	  to	  37	  °C,	  
rapidly	  melted.	  Cells	  leL	  to	  
precipitate	  for	  30	  minutes.	  
Frequent	  vortexing	  
Cells	  centrifuged	  at	  7000	  G	  for	  
7	  minutes	  at	  4	  °C	  
FiltraPon	  
Supernatant	  diluted	  20	  fold	  
and	  passed	  over	  strong	  anion	  
exchange	  Q-­‐sepharose	  fast	  
flow	  column	  
NucleoPdes	  eluted	  from	  Q-­‐
sepharose	  column	  with	  2	  M	  
LiCl	  in	  25	  mM	  Tris	  pH	  8	  
NucleoPdes	  precipitated	  O/N	  
in	  96	  %	  EtOH	  in	  the	  presence	  
of	  1	  M	  K2HPO4	  at	  -­‐20	  °C	  
Samples	  centrifuged	  at	  5525	  
G	  at	  4	  °C	  for	  20	  minutes	  	  
Samples	  washed	  with	  cold	  70	  
%	  EtOH	  and	  centrifuged	  for	  20	  
minutes	  at	  5525	  G	  at	  4	  °C	  
Supernatant	  decanted,	  
precipitate	  dried	  and	  diluted	  
in	  cold	  mQ	  
Samples	  centrifuged	  at	  
maximum	  speed	  for	  20	  
minutes	  at	  4	  °C.	  Supernatant	  
collected.	  High	  pressure	  liquid	  
cromatography	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µM	  RelA	  (purified	   from	  E.	  coli	  strain	  BL21	  (DE3)	  cells	  containing	  pET24b	  plasmid	  and	  kanamycin	  resistance)	   	  and	  different	  concentrations	  of	  Relacin	  (from	  0	  to	  5	  mM)	  in	  1x	  Polymix	  (PM)	  buffer	  (25	  mM	  Hepes	  pH	  7.5,	  15	  mM	  MgCl2,	  0.5	  mM	  CaCl,	  95	  mM	  KCl,	  5	  mM	   NH4Cl,	   8	   mM	   putrescine,	   1	   mM	   spermidine,	   5	   mM	   K3PO4	  pH	   7.3	   and	   1	   mM	   1,4-­‐dithioerytreithol).	  	  
After	   incubating	  mixes	   for	   two	  minutes	  at	  37	  °C,	   the	  reaction	  was	  started	  by	  adding	  1	  mM	  ATP	  and	  carried	  out	  at	  37	  °C.	  After	  the	  timepoints	  had	  been	  taken,	  the	  reaction	  was	  stopped	  with	  the	  addition	  of	  Killmix	  (2	  parts	  of	  10	  mM	  GDP,	  10	  mM	  GTP	  to	  5	  parts	  of	  100%	  Formic	  acid).	  One	  sample	  should	  not	  contain	  more	  than	  30%	  Formic	  acid	   in	  the	  end.	  To	  separate	  nucleotides	  2D-­‐TLC	   (Thin	  Layer	  Chromatography)	  method	  was	  used.	  The	   samples	   were	   loaded	   onto	   Polygram	   Cel	   300	   PEI/UV254	   precoated	   TLC	   sheets	  (Mecherey-­‐Nagel)	  and	  the	  chromatography	  ran	  in	  0,5	  K2HPO4	  TLC	  buffer.	  The	  positions	  of	  ppGpp	  and	  its	  substrate,	  GDP,	  were	  located	  and	  those	  parts	  of	  the	  TLC	  sheets	  were	  cut	  out.	   Then	   they	  were	   added	   to	   scintillation	   cocktail	   ScintiSafe3	   (Fischer	   Scientific)	   and	  counted	   for	   (3H)	   radioactivity	   using	   Perkin	   Elmer	   Tri-­‐Carb	   2810TR	   Scintillation	  Analyzer.	  
 
 
1.3 Effect of Relacin on E. coli growth  
On the first day we harvested three E. coli strains – AS19 (with hyper-permeable membrane), 
E. coli wild-type strain BW25113 and the mutant strain missing RelA protein ΔRelA, and 
grew them over-night at 37 °C. We started three E. coli cultures in 3 ml of M9 medium 
(CaCl2, MgSO4, M9 salts (Table 3), glucose as a carbon source),  from LB plates to grow for 
17 hours in 37 °C shaker to prolong their stationary phase. Next day cultures were diluted to 
final concentration OD600 0.05. For every strain we did three separate dilutions. To AS19 we 
added 1 mM and 2 mM Relacin. We didn’t add anything to wild-type and mutant strain. We 
put samples to 96 well-plate, 100 µl of every dilution. Borders of the plate were filled with the 
medium M9 to measure ”blank” sample and later count results taking ”blank” measurement 
into account. Plate was closed, properly wrapped with parafilm and placed into the microplate 
reader (FLUOstar Omega). Basic settings for the protocol are given in Table 4. 
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Table 3. 10xM9 salts 
Components Final concentration (mM) 
KH2PO4 22 
NaCl 9 
NH4Cl 19 
Na2HPO4 42 
MgSO4 1 
CaCl2 0,09 
 
Table 4. Basic settings for micro-plate reader FLUOstar Omega 
 
Basic settings  
Measurment type Absorbance 
Microplate name GREINER 96 F-BOTTOM (light wave path) 
Number of cycles 130 
Cycle time 7 minutes 
Number of flashes per well 30 
Excitation  600 
Shaking frequency (rpm) 700 (maximum) 
Shaking mode orbital 
Additional shaking time 300 seconds after each cycle 
Reading direction → 
Target temperature (°C) 37 
Absorbance path length correction volume (µl) 100 
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2. Results 
The experimental work is mainly based on description of function of the stringent factor, the 
protein called RelA. RelA is responsible for incorporating main nucleotides ATP and GTP or 
GDP into the alarmone called (p)ppGpp during nutrient starvation of bacteria (Chatterji & 
Ojha, 2001). Therefore, RelA plays an important role in formation of quantities of nucleotide 
pools during the stringent response.  
During the experiments we complemented the method of measuring the quantity of nucleotide 
pools in E. coli by Buckstein and colleagues, we found ways to elaborate it considerably. 
Next, we applied our new method by testing a novel antibacterial agent, ppGpp analogue 
Relacin on E. coli in vivo. Relacin effect on RelA was also studied in vitro.  
Wexselblatt and colleagues showed that Relacin inhibits E. coli RelA in vitro and prevent B. 
subtilis	  sporulation . In current work, for in vitro studies, we used E. coli RelA but in vivo 
studies were carried out with E. coli strain AS19 that has defective LPS. AS19 was used 
because E. coli, as all Gram-negative bacteria, has an outer membrane and periplasmic 
structures that prevent many compounds to enter the cell.  
 
2.1 Measurement of nucleotide pools in vivo 
In order to study stringent response in vivo one has to follow nucleotide levels, for that, we 
started from a method developed by Buckstein and colleagues (Buckstein et al., 2008) and 
elaborated on that considerably. Most notably, we saved sample processing time and increase 
selectivity for nucleotides by LiCl-ethanol precipitation strategy with K2HPO4 as co-
precipitate.  
To test out our new bacterial nucleotide pool quantification method, we sought to observe the 
effects on RelA with added antibiotic mupirocin (3 fold minimal inhibitory concentration) 
which inhibits tRNA-synthetase and protein synthesis (Reiss et al., 2012). We could follow 
the level of the alarmone ppGpp elevated in cells (Figure 7). 
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We found that 3 times MIC mupirocin causes very fast ppGpp accumulation in AS19 cells, so 
that ppGpp levels reached plateau already in five minutes. 
 
 
Figure 7. Induction of ppGpp synthesis in AS19 E. coli in the presence of mupirocin.	  
Cells were grown in 0,4 % glucose MOPS at 37 °C and 3xMIC of mupirocin was added when 
cells reached OD600 0.5. As a result, the level of ppGpp elevated rapidly and acquired a 
plateau in the concentration of ppGpp. As a control we used cells where we didn’t add any 
mupirocin.	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2.2 Effects of Relacin on E. coli RelA in vitro 
The RelA mediated stringent response is at the heart of bacterial adaption to starvation and 
stress, producing the alarmone ppGpp which globally reprograms transcription, translation 
and replication. To investigate the biological activity of the compound Relacin Wexselblatt 
and colleagues evaluated its inhibitory potential on the (p)ppGpp synthethase activity of 
RelA. We tried to repeat the experiment to test the results presented in the article (Wexselblatt 
et al., 2012) (Shyp et al., 2012). 
The protein RelA was purified from E. coli strain BL21 (DE3), using the plasmid pET24b, the 
strain had the kanamycin resistance. To inhibit RelA we used a ppGpp analogue antibacterial 
agent Relacin. The in vitro assay was developed by Hauryliuk and colleagues (Shyp et al., 
2012). The main reaction was carried out in polymix. We had a stock of relacin which was 
diluted in mQ, we re-diluted it in polymix as the main reaction was carried out in polymix to 
avoid pH misbalance. We used liquid scintillation analyzer to count the conversion of GDP to 
ppGpp. Process of reaction was quantified as 3H-GDP to 3H-ppGpp conversion, ranging from 
0 (no 3H-ppGpp is produced) to 1 (all the 3H-GDP is converted to 3H-ppGpp). 
We calculated the conversion of GDP to ppGpp and plotted it against the reaction time 
(Figure 8). Next we calculated turnover of ppGpp per RelA molecule per minute and 
displayed it against Relacin concentration (Figure 9).  
As a result displayed on the chart we can see that conversion of GDP to ppGpp does decrease 
over time as concentration of Relacin increases in the reaction mixture. There is almost no 
conversion of GDP to ppGpp in the presence of 5 mM Relacin. This means that Relacin binds 
to RelA and does not allow the synthesis of ppGpp. 
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Figure 8. Conversion of GDP to ppGpp in the presence of Relacin. The main reaction was carried 
out in polymix, where 70 S ribosomes, ppGpp, 6His RelA, and tritiated GDP at 37 °C. We activated 
reaction with ATP and stopped reaction with killmix. The time points were taken at 5, 10, 20 and 30 
minutes and concentrations of Relacin were 0, 0.1, 0.5, 1, 2 and 5 mM. There is a correlation between 
concentration of Relacin and conversion of GDP to ppGpp. The strongest effect is shown in the 
presence of 5 mM Relacin and lowest is without Relacin. ppGpp analogue Relacin does inhibit RelA 
in vitro and prevents the synthesis of the alarmone ppGpp where GDP is used as a substrate. Both 
GDP and ppGpp are tritiated. 
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To show that inhibition of ppGpp synthesis is in fact caused by Relacin binding to RelA we 
calculated the turnover of ppGpp per RelA molecule per minute. Following chart shows that 
as the concentration of Relacin increases the activity of reaction – synthesis of ppGpp by 
RelA decreases. These results support the claim of Wexselblatt that Relacin in fact binds to 
the stringent factor and disturbs RelA to produce ppGpp (Wexselblatt et al., 2012). 
 
 
 
Figure 9.  Inhibition of RelA by Relacin in vitro. The main reaction was carried out in polymix, 
where 70 S ribosomes, ppGpp, 6His RelA and tritiated GDP at 37 °C. We activated reaction with ATP 
and stopped reaction with killmix. The time points were taken at 5, 10, 20 and 30 minutes and 
concentrations of Relacin were 0, 0.1, 0.5, 1, 2 and 5 mM. In growing concentrations of ppGpp 
analogue Relacin the RelA activity decreases and synthesis of ppGpp per minute slows down. In the 
presence of 5 mM Relacin the reaction is almost stopped and no ppGpp is synthesized. Errors bars 
stand for standard deviation. 
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2.3 Effect of Relacin on E. coli growth 
 
For this experiment instead of B. subtilis we used E. coli strain AS19. As a control we used E. 
coli wild-type strain BW25113 and E. coli mutant strain ΔRelA which is missing protein 
RelA. We used M9 minimal medium.  
 
The hypothesis was that the strain with missing RelA enters exponential phase later than wild-
type strain but grows as fast as wild-type strain. The same effect we hoped to see on AS19 in 
presence of Relacin, because Relacin should inhibit the protein RelA. 
 
At the same time we observed the growth curves of AS19 in the presence of Relacin. Relacin 
inhibits synthesis of ppGpp, the lower is the concentration of ppGpp the faster it grows. 
Therefore, the higher is the concentration of Relacin the lower is the concentration of ppGpp 
and bacteria grows faster. Moreover, Relacin should prevent bacteria to go to stationary 
phase. 
 
The results weren’t those we expected (Figure 10). Even though the mutant strain ΔRelA did 
enter exponential phase later than wild-type strain, the strain AS19 in the presence of Relacin 
didn’t show any drastic changes comparing to the sample without Relacin, especially 
comparing the concentrations of 1 mM and 2 mM. So we conclude that Relacin doesn’t have 
any effect on E. coli in vivo. There may be many explanations but the most likely one is that 
Relacin simply didn’t enter the cell. Mutant strain ΔRelA and wild-typee strain BW25113 
didn’t reach stationary phase. 
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Figure 10. Effect of Relacin the growth of E. coli AS19. Cells were grown in M9 minimal medium 
at 37 °C. Strain AS19 was grown in the presence of Relacin – 1 mM and 2 mM. As a control we used 
E. coli wild-type strain BW25113, mutant strain missing protein RelA ΔRelA (or RelA KO) and strain 
AS19 without Relacin. The wild-type strain and mutant strain didn’t enter the stationary phase. AS19, 
on the contrary, had entered the stationary phase. There are no drastic changes in growth speed of cells 
in the presence of Relacin (1 mM and 2 mM). The Relacin doesn’t affect the growth of E. coli strain 
AS19.  
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Discussion and outlook 
 
The main targets for antibiotics in bacterial cells are protein synthesis, folate acid synthesis, 
nucleic acid synthesis and cell wall synthesis (Walsh, 2003). In the last 40 years a limited 
number of new antibotic classes have been introduced and dramatical increase in antibotic 
resistance is compromising the efficiency of available compounds. One promising direction is 
targeting bacterial systems responsible for bacterial virulence. The main advantage of this 
strategy is lower selectivity pressure due to non-essentiality of the target and thus, slower 
development of resistance. The stringent response seems to be the perfect target being one of 
the central bacterial regulatory mechanisms. Several ppGpp analogues have been shown to 
inhibit the stringent response in cell-free assays; the ppGpp analogue Relacin was shown to 
inhibit ppGpp-dependent sporulation in bacterial cultures of Bacillus subtilis and ppGpp 
production by the central molecule of the stringent respone – RelA.  
We tried to repeat experiments done with Relacin in vitro and in vivo. For in vitro stringent 
response assay we used elevating concentrations of Relacin on purified RelA protein by 
activating the reaction with ATP and stopping with Killmix, later counting the production of 
ppGpp on Liquid Scintillation Analyzer. Indeed, in higher concentrations of Relacin the 
synthesis of ppGpp almost stopped and RelA activity almost stopped. This confirms that 
Relacin inhibits RelA in a cell-free system. We can conclude that ppGpp analogue which was 
synthesized using RelA homologues occupies the active center of the protein RelA and 
prevents the synthesis of ppGpp. 
Original experiments with Relacin in vivo were done on Gram-positive bacteria Bacillus 
subtilis. We used E. coli strain with a hyper-permeable membrane hoping the compound will 
penetrate cells. We didn’t see any drastic effects on bacterial growth in the presence of 
Relacin. The problem may be addressed to the fact that Relacin didn’t enter cells and small 
fluctuations may be caused by the treatment of samples.  
Above the experiments described in the original paper we repeated (Wexselblatt et al., 2012), 
we managed to improve a method on collecting nucleotides and measuring the nucleotide 
pools in living cells. We used an antibiotic mupirocin which has been shown to elicit the 
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stringent response, thus the levels of ppGpp must elevate. The results showed the rapid 
accumulation of ppGpp. Our pre-liminary results has shown that in wild-type strain the 
accumulation of ppGpp is slower and plateau is reached later.  
Those experiments are a cornerstone for the whole system of developing novel antibacterial 
agents since the inhibitors of the stringent factor cause the decrease in the concentration of 
ppGpp in the cell which in turn causes the effects on other nucleotide pools. The effects must 
be studied on single proteins and on bacterial physiology in vivo. Changes in levels of even 
standard nucleotides (for example GDP or ATP) may affect bacterial physiology.  
The aim of our project is to develop new stringent response inhibitors and because of that our 
main target is now investigation of effects of Relacin on B. subtilis in bacterial culture and 
determination of nucleotide quantities in vivo in the presence of Relacin. 
There are several new ppGpp derivatives which are in process of testing on Rel-A mediated 
stringent response, for example an adenine analogue of ppGpp ppApp and pGp, a ppGpp 
analogue with reduced phosphate groups. A 6-G-thio derivative of ppGpp was identified as a 
strong inhibitor for RelA. 
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Summary 
The stringent response is central bacterial regulatory pathway mediated by the alarmones 
collectively called (p)ppGpp. In the cell the levels of (p)ppGpp are controlled by the RelA-
SpoT Homologue enzymes which in turn synthesize or degrade the alarmone in response to 
different stress stimuli, like nutrient starvation, fatty acid deficiency, heat shock etc. ppGpp 
modulates a number of various enzymes: RNA polymerase, translational GTPases and more 
importantly it activates ppGpp-synthetic activity of RelA itself.  
Since the stringent response regulates bacterial virulence and antibiotic tolerance, it is 
promising to develop specific inhibitors which may lead to designing novel antibacterial 
agents. For example, the stringent response is bound to biofilm formation which is a big 
problem in a medical world since antibiotics can’t target non-dividing cells. 
In this work we investigated the effects of the novel antibacterial agent, ppGpp analogue, 
Relacin which was synthesized using the crystal structure of the RelA protein. The original 
work was done using B. subtilis bacterial culture and the RelA purified from E. coli. We 
found that Relacin inhibits work of the RelA in vitro. In the growing concentrations Relacin 
did inhibit the synthesis of ppGpp. For in vivo system we used a E. coli strain with hyper-
permeable membrane and didn’t see any changes in bacterial growth in cultures with Relacin. 
In addition, we managed to complete a method for extracting nucleotides from cells to 
measure nucleotide pools on high pressure liquid chromatography.  
The outlook of our project is to test Relacin on B. subtilis bacterial culture and try to collect 
and measure nucleotides in the presence of Relacin. Broader aim is to try testing synthesized 
ppGpp analogues on the stringent factor RelA and develop efficient and specific ppGpp 
stringent response inhibitors with good pharmacokinetic features. This work may be a 
threshold for developing a new group of drugs. 
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ppGpp-sarnased poomisvastuse pärssijad: in vivo ja in vitro 
iseloomustamine 
Katarina-Beata Saltõkova 
Resümee 
Efektiivsemaks toimimiseks ja ellujäämiseks peavad bakterid olema suutelised tunnetama 
muutusi ümbritsevas keskkonnas ja kohanema muutustega kiiresti. Toitainete puuduses on 
mõistlik lülitada geeniekspressiooni ümber hädavajalikele mehhanismidele või kohasust 
tõstvatele füsioloogistele reaktsioonidele. Üks tähtsamaid vastuseid näljastressitingimustele 
on poomisvastus ehk stringent response. Seda vahendavad GDP ja GTP derivaadid, guanosiin 
tetra- ja pentafostaat, (p)ppGpp. (p)ppGpp metabolismiga tegelevad Rel/Spo homoloogide 
perekonda kuuluvad valgud, mis sünteesivad ja lagundavad (p)ppGppd. (p)ppGpp ise mõjutab 
mitmeid ensüüme rakus, näiteks RNA polümeraasi, translatsioonilisi GTPaase ja ka RelA 
valku ennast, olles iseenda sünteesi positiivseks regulaatoriks. 
Poomisvastus on tihedalt seotud bakterite virulentsusega ja antibiootikumide taluvusega, mis 
on üha kasvav probleem meditsiinimaailmas; bakterite resistentsete spooride teke on ppGpp-
sõltuv protsess, poomisvastus on tihedalt seotud biofilmide tekkimisega. Antibiootikumidel ei 
ole mõju mittejagunevatel ehk statsionaarses faasis olevatel rakkudel. Seepärast on 
poomisvastuse mehhanismi uurimine esmatähtsal kohal just selle pärssimise seisukohalt. 
Viimasel ajal on hakatud looma uusi aineid, mis struktuurilt sarnanevad ppGpp molekuliga. 
Üheks selliseks aineks on uus antibakteriaalne mõjur Relacin. Relacin sünteesiti kasutades 
RelA valgu kristallstruktuuri. Suuremates kogustes inhibeerib Relacin RelAd rakuvabas 
süsteemis ja ppGpp sünteesi elusates kultuurides. Originaalartiklis kasutati E. colist eraldatud 
RelA valk ja in vivo katsed viidi läbi B. subtilise tüvel. Antud töös kordasime osasid katseid, 
bakteritüvena kasutasime E. coli tüve defektse lipopolüsahhariidse membraaniga, mis 
võimaldab ainetel võimalikult kergesti rakku pääseda. In vitro süsteemis inhibeeris Relacin 
RelA valku; bakterikultuuris ei olnud Relacini mõjutused märgatavad, mille põhjuseks võib 
olla aine mitte pääsemine rakku. Antud katsete kõrval suutsime täiendada nukleotiidide 
eraldamise meetodit rakkudest. Lihtsamate nukleotiidide (nagu näiteks ATP või GDP) 
reservuaarid rakus võivad oluliselt mõjutada bakterite füsioloogiat, seepärast on nende 
mõõtmine tähtsaks teguriks kirjeldamaks bakterites toimuvaid füsioloogilisi muutusi.  
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Meie edasine eesmärk on testida Relacini B. subtilise tüvel ning võrrelda Gram-positiivsete ja 
Gram-negatiivsete bakterite vastust antud ainele, jälgides bakterite kasvu ja nukleotiidide 
reservuaaride muutumist. Relacin pole ainus sünteesitud aine oletatavalt RelA valgu 
inhibeerivate omadustega, hiljuti on nimekirjale lisandunud adenosiini analoog ppApp ja 
ppGpp analoog, millel puuduvad kaks fosfaatrühma, pGp. Kavas on testida ka neid aineid nii 
rakuvabas süsteemis, rakukultuuris jälgida bakterite kasvu ja mõju nukleotiididele. Pikemas 
perspektiivis loodetakse selliste katsete käigus luua heade farmakokineetiliste omadustega 
antibakteriaalsed ained, mis võiksid tulevikus levida edasi ravimitööstusesse ning luua uue 
antibiootikumide mõjuspektri. 
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